XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.33

-8.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (10327)	6/3/1999 2:03:00 PM
From: Cacaito	Read Replies (2) of 17367

RK, 62 cases for estimating overall mortality for "arrivals" is appropriate for imaginations.... ... the "bpi distortion" effect, this is bpi efficacy... RK likes : 17 + 62 = 79/(198 + 62) = 40%, for an estimate of the lowest possible non bpi cases (assuming zero efficacy, and 100% safety). (It seems that you agree with GW). ... is 8% low?....for patients in shock?... ...does Xoma has agreement with GNE? or Roche? the old GNE? or the recycled GNE IPO? ...does Roche needs Vitamins? ... Japan is a deal on its own.... ...BOL is my first US choice... ...disclaimers apply... ... Bermuda sand pink? real? painted?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next